Modulation of erythropoietin delivery from engineered muscles in mice

Human Gene Therapy

Volumn 8, Issue 2, 1997, Pages 195-204

  Bohl, Delphine ^a   Heard, Jean Michel ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DESMIN; ERYTHROPOIETIN; MESSENGER RNA; MITOMYCIN; TETRACYCLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENHANCER REGION; EXPRESSION VECTOR; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSDUCTION; HEMATOCRIT; MALE; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; NORTHERN BLOTTING; PROMOTER REGION; REGULATOR GENE; RETROVIRUS; SKELETAL MUSCLE; TRANSCRIPTION REGULATION;

EID: 0031046584     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.2-195     Document Type: Article

References (64)

1. AGARWAL, M.L., AGARWAL, A., TAYLOR, W.R., and STARK, G.R. (1995). p53 controls both the G2/M and the G1 cell cycle checkpoint and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA 92, 8493-8497.
2. BARR, E., and LEIDEN, J.F. (1991). Systemic delivery of recombinant proteins by genetically-modified myoblasts. Science 254, 1507-1509.
3. BAUER, T.R., JR, OSBORNE, W.R.A., KWOK, W.W., and HICKSTEIN, D.D. (1994). Expression from leukocyte integrin promoters in retroviral vectors. Hum. Gene Ther. 5, 709-716.
4. CAO, J., PARK, I., COOPER, A., and SODROSKI, J. (1996). Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1. J. Virol. 70, 1340-1354.
5. CAYROL, C., and FLEMINGTON, E.K. (1995). Identification of cellular target genes of the Epstein-Barr virus transactivator Zta activation of transforming growth factor beta igh3 (TGF-beta igh3) and TGF-beta1. J. Virol. 69, 206-212.
6. CLOWES, M.M., LYNCH, C.M., MILLER, A.D., MILLER, D.G., OSBORNE, W.R.A., and CLOWES, A.W. (1994). Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes. J. Clin. Invest. 93, 644-651.
7. CONE, R.D., WEBER-BENAROUS, A., BAORTO, D., and MULLIGAN, R.C. (1987). Regulated expression of a complete human β-globin gene encoded by a transmissible retrovirus vector. Mol. Cel. Biol. 7, 887-897.
8. DAI, Y., ROMAN, M., NAVIAUX, R.K., and VERMA, I.M. (1992). Gene therapy via primary myoblasts: Long-term expression of factor IX protein following transplantation in vivo. Proc. Natl. Acad. Sci. USA 89, 10892-10895.
9. DANOS, O., and MULLIGAN, R.C. (1988). Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA 85, 6460-6464.
10. DAVIS, H.L., WHALEN, R.G., and DEMENEIX, B.A. (1993). Direct gene transfer into skeletal muscle in vivo: Factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4, 151-159.
11. DESCAMPS, V., BLUMENFELD, N., PERRICAUDET, M., BEUZARD, Y., and KREMER, E.J. (1995). Organoids direct systemic expression of erythropoietin in mice. Gene Ther. 2, 411-417.
12. DHAWAN, J., PAN, L.C., PAVLATH, G.K., TRAVIS, M.A., LANCTOT, A.M., and BLAU, H.M. (1991). Systemic delivery of human growth hormone by injection of genetically-modified myoblasts. Science 254, 1509-1512.
13. DINGERMANN, T., FRANK-STOLL, U., WERNER, H., WISSMAN, A., HILLEN, W., JACQUET, M., and MARSCHALEK, R. (1992a). RNA polymerase III catalysed transcription can be regulated in Saccharomyces cerevisiae by the bacterial tetracycline repressor-operator system. EMBO J. 11, 1487-1492.
14. DINGERMANN, T., WERNER, H., SCHÜTZ, A., ZÜNDORF, I., NERKE, K., KNECHT, D., and MARSCHALEK, R. (1992b). Establishment of a system for conditional gene expression using an inducible tRNA suppressor gene. Mol. Cell. Biol. 12, 4038-4045.
15. DWARKI, V.J., BELLONI, P., NIJJAR, T., SMITH, J., COUTO, L, RABIER, M., CLIFT, S., BERNS, A., and COHEN, L.K. (1994). Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice. Proc. Natl. Acad. Sci. USA 92, 1023-1027.
16. EFRAT, S., FUSCO-DEMANE, D., LEMBERG, H., AL EMRAN, O., and WANG, X. (1995). Conditional transformation of a pancreatic b-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. Proc. Natl. Acad. Sci. USA 92, 3576-3580.
17. EMERMAN, M., and TEMIN, H.M. (1984a). Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism. Cell 39, 459-467.
18. EMERMAN, M., and TEMIN, H.M. (1984b). High-frequency deletion in recovered retrovirus vectors containing exogenous DNA with promoters. J. Virol. 50, 42-49.
19. EMERMAN, M., and TEMIN, H.M. (1986). Quantitative analysis of gene suppression in integrated retrovirus vectors. Mol. Cell. Biol. 6, 792-800.
20. FENJVES, E.S., SMITH, J., ZARADIC, S., and TAICHMAN, L.B. (1994). Systemic delivery of secreted protein by grafts of epidermal keratinocytes: prospects for keratinocyte gene therapy. Hum. Gene Ther. 5, 1241-1248.
21. FISHMAN, G.I., KAPLAN, M.L., and BUTTRICK, P.M. (1994). Tetracycline-regulated cardiac gene expression in vivo. J. Clin. Invest. 93, 1864-1868.
22. FURTH, P.A., ST. ONGE, L., BÖGER, H., GRUSS, P., GOSSENS, M., KISTNER, A., BUJARD, H., and HENNIGHAUSEN, L. (1994). Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl. Acad. Sci. USA 91, 9302-9306.
23. GATZ, C., KAISER, A., and WENDENBURG, R. (1991). Regulation of a modified CaMV 35S promoter by the Tn10-encoded Tet repressor in transgenic tobacco. Mol. Gen. Genet. 227, 229-237.
24. GOSSEN, M., and BUJARD, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89, 5547-5551.
25. GOSSEN, M., FREUNDLIEB, S., BENDER, G., MÜLLER, G., HILLEN, W., and BUJARD, H. (1995). Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769.
26. GUILD, B.C., FINER, M.H., HOUSMAN, D.E., and MULLIGAN, R.C. (1988). Development of retrovirus vectors useful for expressing genes in cultured murine embryonal cells and hematopoietic cells in vivo. J. Virol. 62, 3795-3801.
27. HAMAMORI, Y., SAMAL, B., TIAN, J., and KEDES, L. (1994). Persistent erythropoiesis by myoblast transfer of erythropoietin cDNA. Hum. Gene Ther. 5, 1349-1356.
28. HAMAMORI, Y., SAMAL, B., TIAN, J., and KEDES, L. (1995). Myoblast transfer of human erythropoietin gene in a mouse model of renal failure. J. Clin. Invest. 95, 1808-1813.
29. HATZOGLOU, M., PARK, E., WYNSHAW-BORIS, A., CHENG KAUNG, H., and HANSON, R.W. (1988). Hormonal regulation of chimeric genes containing the phosphoenolpyruvate carboxykinase promoter regulatory region in hepatoma cells infeced by murine retroviruses. J. Biol. Chem. 263, 17798-17808.
30. HEARTLEIN, M.W., ROMAN, V.A., JIANG, J.L., SELLERS, J.W., ZULIANI, A.M., TRECO, D.A., and SELDEN, R.F. (1994). Long-term production and delivery of human growth hormone in vivo. Proc. Natl. Acad. Sci. USA 91, 10967-10971.
31. HOFMAN, A., NOLAN, G., and BLAU, H.B. (1996). Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc. Natl. Acad. Sci. USA 93, 5185-5190.
32. HOWE, J.R., SKRYABIN, B.V., BELCHER, S.M., ZERILLO, C.A., and SCHMAUSS, C. (1995). The responsiveness of a tetracycline-sensitive expression system differs in different cell lines. J. Biol. Chem. 270, 14168-14178.
33. IIDA, A., CHEN, S.T., FRIEDMANN, T., and YEE, J.K. (1996). Inducible gene expression by retrovirus-mediated transfer of a modified tetracycline-regulated system. J. Virol. 70, 6054-6059.
34. JENSEN, J.D., JENSEN, L.W., and MADSEN, J.K. (1994). The pharmacokinetics of recombinant human erythropoietin after subcutaneous injection at different sites. Eur. J. Clin. Pharmacol. 46, 333-337.
35. KIM, H.J., GATZ, C., HILLEN, W., and JONES, T.R. (1995). Tetracycline repressor-regulated gene repression in recombinant human cytomegalovirus. J. Virol. 69, 2565-2573.
36. LI, Z., and PAULIN, D. (1991). High level desmin expression depends on a muscle-specific enhancer. J. Biol. Chem. 266, 6562-6570.
37. LI, Z., and PAULIN, D. (1993). Different factors interact with myoblast-specific and myotube-specific enhancer regions of the human desmin gene. J. Biol. Chem. 268, 10403-10415.
38. MINTY, A., CARAVATTI, M., ROBERT, B., COHEN, A., DAUBAS, P., WEYDERT, A., GROS, F., and BUCKINGHAM, M. (1981). Mouse actin messenger RNAs. J. Biol. Chem. 256, 1008-1014.
39. MONTARRAS, D., PINSET, C., CHELLY, J., KAHN, A., and GROS, F. (1989). Expression of MyoDl coincides with terminal differentiation in determined but inducible muscle cells. EMBO J. 8, 2203-2207.
40. MOULLIER, P., BOHL, D., CARDOSO, J., HEARD, J.M., and DANOS, O. (1995). Long term delivery of lysosomal enzyme by genetically-modified fibroblasts in dogs. Nature Med. 1, 353-358.
41. MOULLIER, P., BOHL, D., HEARD, J.M., and DANOS, O. (1993a). Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically-modified skin fibroblasts. Nature Genet. 4, 154-159.
42. MOULLIER, P., MARÉCHAL, V., DANOS, O., and HEARD, J.M. (1993b). Continuous systemic secretion of a lysosomal enzyme by genetically-modified mouse skin fibroblasts. Transplantation 56, 427-432.
43. NAFFAKH, N., PINSET, C., MONTARRAS, D., LI, Z., PAULIN, D., DANOS, O., and HEARD, J.M. (1996). Long-term secretion of therapeutic proteins from genetically-modified skeletal muscles. Hum. Gene Ther. 7, 11-21.
44. NAFFAKH, N., VILLEVAL, J.L., MOULLIER, P., HENRI, A., ROUYER-FESSARD, P., DANOS, O., HEARD, J.M., and BEUZARD, Y. (1995). Sustained delivery of erythropoietin in mice by autologous implants of genetically-modified skin fibroblasts. Proc. Natl. Acad. Sci. USA 92, 3194-3198.
45. OSBORNE, W.A., RAMESH, N., LAU, S., CLOWES, M.M., DALE, D.C., and CLOWES, A.W. (1995). Gene therapy for long-term expression of erythropoietin in rats. Proc. Natl. Acad. Sci. USA 92, 8055-8058.
46. PASSMAN, R.S., and FISHMAN, G.I. (1994). Regulated expression of foreign genes in vivo after germline transfer. J. Clin. Invest. 94, 2421-2425.
47. PAULUS, W., BAUR, I., BOYCE, F.M., BREAKEFIELD, X.O., and REEVES, S.A. (1996). Self-contained, tetracycline-regulated retroviral system for gene delivery to mammalian cells. J. Virol. 70, 62-67.
48. RESNITZKY, D., HENGST, L., and REED, S.I. (1995). Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1. Mol. Cell. Biol. 15, 4347-4352.
49. RÖDER, F.T., SCHMÜLLING, T., and GATZ, C. (1994). Efficiency of the tetracycline-dependent gene expression system: Complete suppression and efficient induction of the rolB phenotype in transgenic plants. Mol. Gen. Genet. 243, 32-38.
50. ROMAN, M. AXELROD, J.H., DAI, Y., NAVIAUX, R.K., FRIEDMANN, T., and VERMA, I.M. (1992). Circulating human or canine factor IX from retrovirally transduced primary myoblasts and established myoblast cell lines grafted into murine skeletal muscle. Somat. Cell Mol. Genet. 18, 247-258.
51. SAKAGUCHI, M., KOISHIHARA, Y., TSUDA, H., FUJIMOTO, K., SHIBUYA, K., KAWAKITA, M., and TAKASTUKI, K. (1987). The expression of functional erythropoietin receptors on an interleukin-3 dependent cell line. Biochem. Biophys. Res. Commun. 146, 7.
52. SALMONSON, T., DANIELSON, B.G., and WIKSTROM, B. (1990). The pharmacokinetics of recombinant erythropoeitin after intravenous and subcutaneous administration to healthy subjects. Br. J. Pharmacol. 29, 703-713.
53. SALVETTI, A., MOULLIER, P., CORNET, V., BROOKS, D., DANOS, O., and HEARD, J.M. (1995). In vivo delivery of human α-L-iduronidase in mice implanted with neo-organs. Hum. Gene Ther. 6, 1153-1159.
54. SHOCKETT, P., DIFILIPPANIONIO, M., HELLMAN, N., and SCHATZ, D. (1995). A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc. Natl. Acad. Sci. USA 92, 6522-6526.
55. SORIANO, P., FRIEDRICH, G., and LAWINGER, P. (1991). Promoter interactions in retrovirus vectors introduced into fibroblasts and embryonic stem cells. J. Virol. 65, 2314-2319.
56. TRIPATHY, S.K., BLACK, H.B., GOLDWASSER, E., and LEIDEN, J.M. (1996). Immune response to transgene-encoded proteins limits the stability of gene expression after injections of replication-defective adenovirus vectors. Nature Med. 2, 545-549.
57. TRIPATHY, S.K., GOLDWASSER, E., LU, M.M., BARR, E., and LEIDEN, J.M. (1994). Stable delivery of physiological levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc. Natl. Acad. Sci. USA 91, 11557-11561.
58. VILE, R., MILLER, N., CHEMAJOVSKY, Y., and HART, I. (1994). A comparison of the properties of different retroviral vectors containing the murine tyrosinase promoter to achieve transcriptionally targeted expression of the HSVtk or IL2 genes. Gene Ther. 1, 307-316.
59. WIMMEL, A., LUCIBELLO, F.C., SEWING, A., ADOLPH, S., and MULLER, R. (1994). Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E. Oncogene 9, 995-997.
60. WIRTZ, E., and CLAYTON, C. (1995). Inducible gene expression in trypanosomes mediated by a prokaryotic repressor. Science 268, 1179-1183.
61. WU, X., HOLSCHEN, J., KENNEDY, S.C., and PONDER, K.P. (1996). Retroviral vector sequences may interact with some internal promoters and influence expression. Hum. Gene Ther. 7, 159-171.
62. YAO, S.N., SMITH, K.J., and KURACHI, K. (1994). Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice. Gene Ther. 1, 99-107.
63. YEE, J.K., MOORES, J., JOLLY, D., WOLLF, J., RESPESS, J., and FRIEDMANN, T. (1987). Gene expression from transcriptionally disabled retroviral vectors. Proc. Natl. Acad. Sci. USA 84, 5199-5201.
64. YU, S., VON RUDEN, T., KANTOFF, P.W., GARBER, C., SEIBERG, M., RÜTHER, U., ANDERSON, W.F., WAGNER, E.F., and GILBOA, E. (1986). Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc. Natl. Acad. Sci. USA 83, 3194-3198.